1-12 of 12
Steven Le Gouill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registry

Open Access
Federico Erbella, Emmannuel Bachy, Guillaume Cartron, Elodie Gat, Guillaume Manson, Franck Morschhauser, Francois-Xavier Gros, Louise Roulin, Benoit Tessoulin, Pierre Bories, Olivier Tournilhac, Laure Ricard, Stephanie Guidez, Sylvain Choquet, René-Olivier Casasnovas, Gabriel Brisou, Arnaud Campidelli, Cristina Castilla-Llorente, Fabrice Jardin, Emmanuel Gyan, Blandine Guffroy, Julie Abraham, Justine Decroocq, Adrien Chauchet, Magalie Joris, Fabien Claves, Sylvain Carras, Gaelle Guillerm, Michael Loschi, Olivier Hermine, Aline Schmidt, Steven Le Gouill, Roch Houot, Roberta Di Blasi
Journal: Blood Advances
Blood Adv bloodadvances.2025016727.
https://doi.org/10.1182/bloodadvances.2025016727
Published: 2025
Includes: Supplemental data
Journal Articles

Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy: A Descar-T Study By Lysa Group

Open Access
Marion Aymard, Morgane Cheminant, Roch Houot, Anne Cuozzo, Elodie Gat, Catherine Thieblemont, Laure Ricard, Louise Roulin, Krimo Bouabdallah, Violaine Safar, Stephanie Guidez, Amandine Fayard, Gabriel Brisou, Loic Ysebaert, Olivier Hermine, Benoit Tessoulin, Charles Herbaux, Steven Le Gouill, Clémentine Sarkozy
Journal: Blood Advances
Blood Adv bloodadvances.2025017234.
https://doi.org/10.1182/bloodadvances.2025017234
Published: 2025
Includes: Supplemental data
Journal Articles

Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study

Open Access
Sarah Cayla, Lionel Karlin, Jerome Lambert, Anne Lazareth, Alexis Talbot, Mohamad Mohty, Florent Malard, Marie-Odile Petillon, Salomon Manier, Ibrahim Yakoub-Agha, Denis Caillot, Ingrid Lafon, Xavier Leleu, Niels Moya, Bruno Royer, Jean Marc Schiano de Colella, Gabriel Brisou, Cyrille Touzeau, Aurore Perrot, Pierre Bories, Laure Vincent, Hanane Guedon, Olivier Decaux, Benoît Ferment, Roch Houot, Steven Le Gouill, Noemie Bigot, Thierry Facon, Jill Corre, Hervé Avet-Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood Advances
Blood Adv bloodadvances.2025017597.
https://doi.org/10.1182/bloodadvances.2025017597
Published: 2025
Includes: Supplemental data
Journal Articles

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas

Open Access
Clinical Trials & Observations
Pierre Stephan, Roberta Di Blasi, Louise Roulin, Jean Galtier, Julien Calvani, Véronique Meignin, Marie Donzel, Alexandra Traverse-Glehen, Elsa Poullot, Marie Parrens, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Roch Houot, Francois-Xavier Gros, François Lemonnier, Emmanuel Bachy, Catherine Thieblemont, Pierre Sesques
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4693–4704.
https://doi.org/10.1182/bloodadvances.2025015834
Published: 2025
Includes: Supplemental data
Journal Articles

Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study

Open Access
Clinical Trials & Observations
Olivier Tournilhac, Krimo Bouabdallah, Solene Lecolant, Maya Hacini, Kamel Laribi, Sebastien Bailly, Thibaut Belmondo, Marie M F Maerevoet, Loic Ysebaert, Stephanie Guidez, Steven Le Gouill, Christophe Bonnet, Marc Andre, Jehan Dupuis, Catherine Thieblemont, Emmanuel Bachy, Nicolas Daguindau, Franck Morschhauser, Sabine Tricot, Charline Moulin, Anne Banos, Roch Houot, Adrien Chauchet, Emmanuel Gyan, Guillaume Cartron, Hassan Farhat, Vincent Camus, Bernard Drenou, Hacene Zerazhi, David Sibon, Emmanuelle Nicolas Virelizier, Caroline Delette, Sylvia Snauwaert, Sarah Bailly, Richard Delarue, Sylvain Carras, Albane Ledoux-Pilon, Marie Parrens, Samuel Griolet, Philippe Gaulard, Marie-Helene Delfau-Larue, Laurence L de Leval, Gandhi Laurent Damaj
Journal: Blood Advances
Blood Adv bloodadvances.2024015787.
https://doi.org/10.1182/bloodadvances.2024015787
Published: 2025
Includes: Supplemental data
Journal Articles

Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma

Open Access
Clinical Trials & Observations
Vincent Camus, Thierry Molina, Fabienne Desmots, Paul Blanc-Durand, Salim Kanoun, Amine Moslemi, Philippe Ruminy, Steven Le Gouill, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Roch Houot, Catherine Thieblemont, Hervé Maisonneuve, Fabien Claves, Krimo Bouabdallah, Corinne Haioun, Gandhi Laurent Damaj, Luc-Matthieu Fornecker, Robin Noel, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Wivine Bernard, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Jean-Philippe Jais, Josette Brière, Cedric Rossi, Mad-Hélénie Elsensohn, Loïc Chartier, Emmanuel Itti, Fabrice Jardin, Thierry Fest
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2232–2246.
https://doi.org/10.1182/bloodadvances.2024015577
Published: 2025
Includes: Supplemental data
Journal Articles

Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy

Free
Vincent Camus, Roch Houot, Gabriel Brisou, Benoit Tessoulin, Sébastien Bailly, Pierre Sesques, Justine Decroocq, Daphné Krzisch, Lucie Oberic, François Lemonnier, Krimo Bouabdallah, Arnaud Campidelli, Ledraa Tounes, Julie Abraham, Charles Herbaux, Franck Morschhauser, Gandhi Laurent Damaj, Stéphanie Guidez, Sylvain Carras, Luc-Matthieu Fornecker, Sylvain Choquet, Olivier Hermine, Jérome Paillassa, Adrien Chauchet, Olivier Casasnovas, Laurianne Drieu La Rochelle, Cristina Castilla-Llorente, Magalie Joris, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5371–5381.
https://doi.org/10.1182/bloodadvances.2024013726
Published: 2024
Includes: Supplemental data
Journal Articles

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

Free
Clinical Trials & Observations
Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie-Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Rene-Olivier Casasnovas, Magalie Joris, Cristina Castilla-Llorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Franck Morschhauser, Catherine Thieblemont, Roch Houot
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6589–6598.
https://doi.org/10.1182/bloodadvances.2023010624
Published: 2023
Includes: Supplemental data
Journal Articles

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Free
Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, Jean Marc Schiano De colella, Clement Bailly, Salim Kanoun, Stéphanie Guidez, Emmanuel Gyan, Remy Gressin, Nadine Morineau, Loic Ysebaert, Steven Le Gouill, Herve Tilly, Roch Houot, F. Morschhauser, Guillaume Cartron, Charles Herbaux
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3735–3738.
https://doi.org/10.1182/bloodadvances.2023009911
Published: 2023
Includes: Supplemental data
Journal Articles

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Free
Clinical Trials & Observations
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, Benoit Tessoulin, Cedric Rossi, Maud D'Aveni-Piney, Lucie Obéric, Caroline Bodet-Milin, Pierre Bories, Pierre Olivier, Ingrid Lafon, Alina Berriolo-Riedinger, Eugenio Galli, Sophie Bernard, Marie-Thérèse Rubio, Celine Bossard, Veronique Meignin, Pascal Merlet, Pierre Feugier, Steven Le Gouill, Loic Ysebaert, Olivier Casasnovas, Michel Meignan, Sylvie Chevret, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5607–5615.
https://doi.org/10.1182/bloodadvances.2020003001
Published: 2020
Includes: Supplemental data
Journal Articles

Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study

Free
Clinical Trials & Observations
Marie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, Pierre Feugier, Hervé Maisonneuve, Rene-Olivier Casasnovas, François Lemonnier, Gian Matteo Pica, Roch Houot, Loic Ysebaert, Hervé Tilly, Jean-Claude Eisenmann, Steven Le Gouill, Vincent Ribrag, Pascal Godmer, Sylvie Glaisner, Guillaume Cartron, Luc Xerri, Gilles André Salles, Thierry Fest, Franck Morschhauser
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3217–3223.
https://doi.org/10.1182/bloodadvances.2020001955
Published: 2020
Includes: Supplemental data
Journal Articles

p53 regulates CD46 expression and measles virus infection in myeloma cells

Free
Anne Lok, Geraldine Descamps, Benoit Tessoulin, David Chiron, Marion Eveillard, Catherine Godon, Yannick Le Bris, Astrid Vabret, Celine Bellanger, Laurent Maillet, Sophie Barillé-Nion, Marc Gregoire, Jean-François Fonteneau, Steven Le Gouill, Philippe Moreau, Frederic Tangy, Martine Amiot, Agnes Moreau-Aubry, Catherine Pellat-Deceunynck
Journal: Blood Advances
Blood Adv (2018) 2 (23): 3492–3505.
https://doi.org/10.1182/bloodadvances.2018025106
Published: 2018
Includes: Supplemental data